Table 2 Variant assessment for three glutamic acid to lysine substitutions in COL3A1
F1/F4/F5 | F2/F6 | F3/F7 | |
|---|---|---|---|
c.DNA change | c.2044G>A | c.3511G>A | c.721G>A |
Protein change | p.Glu682Lys | p.Glu1171Lys | p.Glu241Lys |
In silico analysis summarya–e | Pathogenic | Equivocal | Equivocal |
Amino acid conservation | Highly conserved | Highly conserved | Moderately conserved |
Grantham distance | Small physicochemical difference between Glu and Lys (Grantham dist=56) | Small physicochemical difference between Glu and Lys (Grantham dist=56) | Small physicochemical difference between Glu and Lys (Grantham dist=56) |
Frequency | Not seen in gnomAD normal populations—supports pathogenicity | Not seen in gnomAD normal populations—supports pathogenicity | Not seen in gnomAD normal populations—supports pathogenicity |
Segregation analysis | F1: Father, son, aunt, and cousins affected and carry the variant; Canadian report also mentions an unaffected family member not carrying the variant; segregates with disease in five generations | F2: Two unaffected family members do not carry the variant F6: both parents thought to be clinically unaffected but only mother confirmed to not carry variant | F3: Not observed in unaffected parents or unaffected son, uninformative segregation analysis F7: No segregation analysis available |
Supporting literature/database records | Supported by the Frank et al. (2015) paper, however this only uses lack of frequency data, AGVD, SIFT, and MutationTaster to support pathogenicity—not ACMG guidelines | In EDS database;f probably pathogenic | |
Variant classification | PS4, PM2, PP3, PP1-S, PP4—pathogenic | PP5, PS4, PM2—likely pathogenic | PM2, PS4-S, PP5, PM6—likely pathogenic |